A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of ACT-541468 in Healthy Young Adults and Elderly Subjects
Clinical trial NCT02571855 · COMPLETED
Trial details
- NCT number
- NCT02571855
- Sponsor
- Idorsia Pharmaceuticals Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-01
- Primary completion
- 2016-02-01
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.